Here at KMK we understand that in order to play optimally in a new disease space you must first understand its market structure, dynamics, and competition. We believe tailored up-to-date data is the best starting point for strategic decision making. To ensure all projects optimally achieve their objectives, research, analysis and insight identification are all performed by senior team members.
To help brands find their place in the market:
- We provide a ‘storylined integration of insights’ vs. a ‘menu dump’ while still delivering a rigorous break down of the market including competitive landscape, saturation points and unmet needs
We help teams define data-based strategies for their new indication, product or acquisition

KMK's cross-business unit expertise incorporates a variety of research types, and the robustness of research is tailored to your needs.
Primary Market Research
Opportunity Assessment
Perception of product & potential use cases
Identification of unmet needs met by product
Unmet Needs Evaluation
Identify white space within the market
Understand who is underserved within market population
Payer Attitudinal Assessment
Gain understanding of payer perspectives
Get guidance on potential access and coverage needs
Baseline ATU
Evaluate current stakeholder awareness and usage
Secondary Data Evaluation
Target Market Potential
Define the market (key drug classes/products)
Market sizing
Historical events impacts
Analogue Identification & Evaluation
Approximate
environmental factors and potential reception including challenges and access
Preliminary Customer Identification & Profiling
Potential by HCP specialty; top specialties/HCPs, early adopters
Potential by account types; top accounts
Patient profile (demographic and clinical)
Referral network analytics
Behavioral segmentation (HCP)
Desk Research
Product Overview
Review and analysis of previously completed research
Asset and pipeline
understanding
Collaborators
KOL identification
Foundation/3rd Party
Investment and research
Advocacy support group analysis
Disease Landscape
Epidemiology
Treatment approaches and clinical guidelines
Treatment algorithm changes over time due to new drug additions or new information
Competitive Landscape
Pipeline assessment
Market events
Get ahead with enhanced market understanding
Our expert market research team is here to guide you, every step of the way. Get in touch today.
Contact Us